Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.12B |
| 2 |
ExxonMobil
XOM
|
+$884M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$856M |
| 4 |
American International
AIG
|
+$594M |
| 5 |
Crown Castle
CCI
|
+$542M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
Gilead Sciences
GILD
|
+$1.23B |
| 3 |
DuPont de Nemours
DD
|
+$982M |
| 4 |
General Motors
GM
|
+$683M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.83% |
| 2 | Technology | 12.2% |
| 3 | Industrials | 11.56% |
| 4 | Communication Services | 11.27% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Silgan Holdings
SLGN
$4.45B
| $94.3M | 0.03% |
3,927,784
+274,784
| +8% | +$6.41M |
|
277
Globe Life
GL
$14.1B
| $93.8M | 0.03% |
1,800,000
| – | – |
|
|
OMG
278
DELISTED
OM GROUP INC.
OMG
| $93M | 0.03% |
2,555,000
| – | – |
|
279
News Corp Class A
NWSA
$15.6B
| $92.3M | 0.03% |
5,120,704
-305,136
| -6% | -$5.27M |
|
280
National Grid
NGG
$81.5B
| $92.3M | 0.03% |
1,464,206
| – | – |
|
281
Ball Corp
BALL
$16.5B
| $88.2M | 0.03% |
3,415,228
+2,304,228
| +207% | +$56.2M |
|
282
Avery Dennison
AVY
$13.5B
| $87.3M | 0.03% |
1,740,051
-484,949
| -22% | -$22.8M |
|
283
Avient
AVNT
$4.21B
| $84M | 0.03% |
2,377,168
-610,000
| -20% | -$19.4M |
|
284
Kimco Realty
KIM
$16.3B
| $81.6M | 0.03% |
4,132,329
| – | – |
|
|
BSMX
285
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $79.4M | 0.03% |
5,820,800
| – | – |
|
286
Eaton
ETN
$177B
| $76.9M | 0.03% |
1,010,000
| – | – |
|
287
Ameren
AEE
$30.2B
| $75.5M | 0.03% |
2,089,120
| – | – |
|
288
Nordson
NDSN
$17.2B
| $75M | 0.03% |
1,010,000
+288,000
| +40% | +$21M |
|
|
HITT
289
DELISTED
HITTITE MICROWAVE CORP
HITT
| $74.7M | 0.03% |
1,210,850
| – | – |
|
|
GTLS
290
DELISTED
Chart Industries
GTLS
| $73.4M | 0.03% |
767,600
-75,000
| -9% | -$7.89M |
|
291
Mercury Insurance
MCY
$5.83B
| $71.8M | 0.03% |
1,444,500
-744,200
| -34% | -$36M |
|
|
OREX
292
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $69.9M | 0.03% |
1,241,830
+384,330
| +45% | +$21.6M |
|
|
TWTC
293
DELISTED
TW TELECOM INC CL A COM
TWTC
| $69.3M | 0.03% |
2,275,000
-240,000
| -10% | -$7.16M |
|
294
Masco
MAS
$14.7B
| $68.3M | 0.03% |
3,414,000
| – | – |
|
295
United Parks & Resorts
PRKS
$2.06B
| $67.6M | 0.03% |
2,350,000
+100,000
| +4% | +$2.98M |
|
|
CRAY
296
DELISTED
Cray, Inc.
CRAY
| $67.4M | 0.02% |
2,453,105
+1,260,105
| +106% | +$29.6M |
|
297
American Electric Power
AEP
$68B
| $67.1M | 0.02% |
1,435,000
| – | – |
|
298
Enviri
NVRI
$572M
| $66M | 0.02% |
2,356,301
+100,000
| +4% | +$2.68M |
|
|
NVDQ
299
DELISTED
Novadaq Technologies Inc.
NVDQ
| $66M | 0.02% |
4,001,648
+637,294
| +19% | +$10.6M |
|
300
Jefferies Financial Group
JEF
$12.8B
| $65.6M | 0.02% |
2,587,087
-125,566
| -5% | -$3.18M |
|
Similar funds
Capital Research Global Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Capital Research Global Investors held 473 positions worth $270B, up 6.6% from $253B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors withdrew a net $8.14B in Q4 2013, closing 44 positions and reducing 142 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $664M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Capital Research Global Investors opened a new position in American International worth $608M.
- Capital Research Global Investors's largest Q4 2013 buy was American International: 11,917,900 shares worth $608M.
- Capital Research Global Investors added most to Amgen in Q4 2013, an estimated $1.12B increase.
- Capital Research Global Investors's biggest Q4 2013 reduction was Microsoft, cutting an estimated $2.44B.
- Capital Research Global Investors fully exited FOREST LABORATORIES INC in Q4 2013, selling an estimated $664M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $270B portfolio in Q4 2013.
- Capital Research Global Investors opened 27 new positions and closed 44 in Q4 2013.
- Capital Research Global Investors's portfolio value rose 6.6% quarter-over-quarter to $270B.
Based on Capital Research Global Investors's 13F filing for Q4 2013, filed 14 Feb 2014.